ACOSTA, MELISSA, W.   NORTON ROSE FULBRIGHT
72
Betreute Anmeldungen
Technische BereichePatente
Biotechnologie29
Medizinische Technologie10
Lebensmittelchemie7
Computer-Technologie5
Pharmazeutika4

Heimatländer der Klienten

Zusammenfassung

ACOSTA, Melissa, W. ist besonders erfahren in den Technologien „Biotechnologie“ und „Medizinische Technologie“. 58% aller Patente wurden im Bereich „(Bio-)Chemie“ betreut. Die wichtigsten Klienten sind „BAYLOR COLLEGE OF MEDICINE“ und „AGENNIX INCORPORATED“. Besonders viele Patentanmeldungen wurden in den Jahren 2003 und 2004 betreut. Die Klienten stammen oftmals aus USA.

Patente nach Jahren

Patente nach Bereichen

5
Patentanmeldungen
11
Patentanmeldungen
42
Patentanmeldungen
6
Patentanmeldungen

Patente nach Anmeldern

RangNameLandPatente
1BAYLOR COLLEGE OF MEDICINEKanada20
2AGENNIX INCORPORATEDUSA12
3MARS, INCORPORATEDUSA9
4ADVANCED NEUROMODULATION SYSTEMS, INC.Kanada8
5BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEMUSA7
6UNIVERSITY OF MARYLAND, BALTIMOREUSA3
7WYETHChina3
8BAYLOR COLLEGE OF MEDECINERussische Föderation2
9DEPARTMENT OF VETERANS AFFAIRSUSA2
10THE TEXAS A & M UNIVERSITY SYSTEMUSA2
11BOARD OF REGENTS, UNIVERSITY OF TEXAS SYSTEMUSA1
12BOND, RICHARD, A.USA1
13DODDS, W., JEANUSA1
14HANKS, BRENTUSA1
15HEMOPETUSA1
16IONWERKS, INC.USA1
17MARS, INC.USA1
18PEDIAMED PHARMACEUTICALS, INC.USA1
19PROTEIN THERAPEUTICS, INC.USA1
20RESEARCH DEVELOPMENT FOUNDATIONUSA1
21SLAWIN, KEVINUSA1
22SPENCER, DAVIDUSA1
23THE GOVERNMENT OF THE USA AS REPRESENTED BY THE SECRETARY OF THE DEPT. OF HEALTH AND HUMAN SERVICESUSA1

Letzte Anmeldungen

PublikationsnummerTitelPatentanmelderJahr
WO2009148692SYSTEMS AND METHODS FOR TREATING AUTISM SPECTRUM DISORDERS (ASD) AND RELATED DYSFUNCTIONSADVANCED NEUROMODULATION SYSTEMS, INC.
2009
WO2009073891SYSTEMS AND METHODS FOR PROVIDING TARGETED NEURAL STIMULATION THERAPY TO ADDRESS NEUROLOGICAL DISORDERS, INCLUDING NEUROPYSCHIATRIC AND NEUROPYSCHOLOGICAL DISORDERSADVANCED NEUROMODULATION SYSTEMS, INC.
2009
WO2008157182METHOD FOR SELECTING ELECTRODES FOR DEEP BRIAN OR CORTICAL STIMULATION AND PULSE GENERATOR FOR DEEP BRIAN OR CORTICAL STIMULATIONADVANCED NEUROMODULATION SYSTEMS, INC.
2008
WO2007050565INCORPORATION OF ANTIMICROBIAL COMBINATIONS ONTO DEVICES TO REDUCE INFECTIONTHE GOVERNMENT OF THE USA AS REPRESENTED BY THE SECRETARY OF THE DEPT. OF HEALTH AND HUMAN SERVICES
BAYLOR COLLEGE OF MEDICINE
2007
WO2006138324TREPONEMA PALLIDUM ANTIGENS FOR VACCINE DEVELOPMENT AND DIAGNOSTIC TESTSBAYLOR COLLEGE OF MEDICINE
2006
WO2006047744COMPOSITIONS OF LACTOFERRIN RELATED PEPTIDES AND USES THEREOFAGENNIX INCORPORATED
2006
WO2006044523BIOMARKERS FOR USE IN VESSEL DISORDERSBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
2006
WO2006036213THE USE OF GAMMAGLOBULIN FOR THE TREATMENT OF PERIODONTAL DISEASEPEDIAMED PHARMACEUTICALS, INC.
2006
WO2006036278THERAPEUTIC AGENTS TARGETING THE NCCa-ATP CHANNEL AND METHODS OF USE THEREOFDEPARTMENT OF VETERANS AFFAIRS
UNIVERSITY OF MARYLAND, BALTIMORE
2006
WO2006034048THERAPEUTIC AGENTS TARGETING THE NCCA-ATP CHANNEL AND METHODS OF USE THEREOFUNIVERSITY OF MARYLAND, BALTIMORE
DEPARTMENT OF VETERANS AFFAIRS
2006
WO2006014896STIMULATION SYSTEM AND METHOD TREATING A NEUROLOGICAL DISORDERADVANCED NEUROMODULATION SYSTEMS, INC.
2006
WO2005113069USE OF CIRCUMIN AND ANALOGUES AS INHIBITORS OF ACC2RESEARCH DEVELOPMENT FOUNDATION
2005
WO2005107858METHOD OF TREATING MOOD DISORDERS AND/OR ANXIETY DISORDERS BY BRAIN STIMULATIONADVANCED NEUROMODULATION SYSTEMS, INC.
2005
WO2005087314BRAIN STIMULATION SYSTEM AND METHODADVANCED NEUROMODULATION SYSTEMS, INC.
2005
WO2005051480ELECTRICAL STIMULATION SYSTEM, LEAD, AND METHOD PROVIDING REDUCED NEUROPLASTICITY EFFECTSADVANCED NEUROMODULATION SYSTEMS, INC.
2005
WO2005046571LACTOFERRIN AS AN ADJUVANT IN CANCER VACCINESAGENNIX INCORPORATED
2005
WO2005032452ALKYL-SUBSTITUTED PCDF AS A TREATMENT FOR PROSTATE CANCERTHE TEXAS A & M UNIVERSITY SYSTEM
2005
WO2005027902MODULATORS OF Cdk9 AS A THERAPEUTIC TARGET IN CARDIAC HYPERTROPHYBAYLOR COLLEGE OF MEDICINE
2005
WO2005018542USE OF LACTOFERRIN IN PROPHYLAXIS AGAINST INFECTION AND/OR INFLAMMATION IN IMMUNOSUPPRESSED SUBJECTSAGENNIX INCORPORATED
2005
WO2004112894METHOD OF TREATING DEPRESSION, MOOD DISORDERS AND ANXIETY DISORDERS USING NEUROMODULATIONADVANCED NEUROMODULATION SYSTEMS, INC.
2004
WO2004109255RAPID SCREENING OF BIOGENIC PARTICLES IN COLLECTED AEROSOLSIONWERKS, INC.
2004
WO2004103285LACTOFERRIN IN THE TREATMENT OF DIABETES MELLITUSAGENNIX INCORPORATED
2004
WO2004094610WNT AS A FACTOR FOR CARDIAC MYOGENESISBAYLOR COLLEGE OF MEDICINE
2004
WO2004092395MODULATORS OF TELOMERE STABILITYBAYLOR COLLEGE OF MEDICINE
2004
WO2004073641INDUCED ACTIVATION IN DENDRITIC CELLSHANKS, BRENT
SLAWIN, KEVIN
SPENCER, DAVID
2004